RecruitingNCT05480644

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Sponsor

Duke University

Enrollment

300 participants

Start Date

Dec 1, 2022

Study Type

OBSERVATIONAL

Conditions

Brain Metastases, Adult Brain Tumor, Primary

Summary

The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting blood samples from adults with primary brain tumors or cancers that have spread to the brain (brain metastases). Researchers will look for biological markers — small signals in the blood — that could one day be used to diagnose or monitor brain tumors without invasive procedures. **You may be eligible if...** - You are an adult with a confirmed diagnosis of a primary brain tumor or a cancer that has spread to the brain (either confirmed by biopsy/pathology or by imaging) **You may NOT be eligible if...** - There are no specific exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.